By removing the stent removals out of the endoscopy suite, we have therefore freed up capacity there and our two-week wait haematuria patients can be seen in these slots instead.
Discover his experience with Isiris α
Oliver Wiseman is a consultant urologist based at Addenbrooke’s Hospital in Cambridge (United-Kingdom). He specialises in the management of patients with kidney stone disease. His role involves managing both general urology patients who have emergency presentations as well as operating on patients with complex kidney stone diseases and with upper tract urothelial cancer.
The income gained by freeing up slots in endoscopy to allow our two-week wait haematuria patients to be seen was greater than the cost of purchasing the Isiris α device.
Using a single use device has also allowed us to remove stents in other places in the hospital.
Isiris α made a significant improvement to quality of care for our patients.
Best of testimonials
Do you feel there are other benefits using single use device?
“As well as the benefits of moving stent removal out of the endoscopy suite and into the lithotripsy suite thus freeing up capacity in endoscopy, using the single-use device has also allowed us to remove stents in other places in the hospital such as: the accident emergency department, up on our urology ward or even on the oncology ward for patients who need to have their stents removed as soon as possible. So I think this has brought significant benefits allowing us flexibility in stent removal in minimising waiting times for patients and therefore, hopefully improving their quality of life and in also keeping the patient journey closer to the stone team which has meant that we have managed to streamline our patients care.”